Drosophila melanogaster models of MPS IIIC (Hgsnat‐deficiency) highlight the role of glia in disease presentation

Sanfilippo syndrome (Mucopolysaccharidosis type III or MPS III) is a recessively inherited neurodegenerative lysosomal storage disorder. Mutations in genes encoding enzymes in the heparan sulphate degradation pathway lead to the accumulation of partially degraded heparan sulphate, resulting ultimate...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of inherited metabolic disease 2024-03, Vol.47 (2), p.340-354
Hauptverfasser: Hewson, Laura, Choo, Amanda, Webber, Dani L., Trim, Paul J., Snel, Marten F., Fedele, Anthony O., Hopwood, John J., Hemsley, Kim M., O'Keefe, Louise V.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 354
container_issue 2
container_start_page 340
container_title Journal of inherited metabolic disease
container_volume 47
creator Hewson, Laura
Choo, Amanda
Webber, Dani L.
Trim, Paul J.
Snel, Marten F.
Fedele, Anthony O.
Hopwood, John J.
Hemsley, Kim M.
O'Keefe, Louise V.
description Sanfilippo syndrome (Mucopolysaccharidosis type III or MPS III) is a recessively inherited neurodegenerative lysosomal storage disorder. Mutations in genes encoding enzymes in the heparan sulphate degradation pathway lead to the accumulation of partially degraded heparan sulphate, resulting ultimately in the development of neurological deficits. Mutations in the gene encoding the membrane protein heparan‐α‐glucosaminide N‐acetyltransferase (HGSNAT; EC2.3.1.78) cause MPS IIIC (OMIM#252930), typified by impaired cognition, sleep–wake cycle changes, hyperactivity and early death, often before adulthood. The precise disease mechanism that causes symptom emergence remains unknown, posing a significant challenge in the development of effective therapeutics. As HGSNAT is conserved in Drosophila melanogaster, we now describe the creation and characterisation of the first Drosophila models of MPS IIIC. Flies with either an endogenous insertion mutation or RNAi‐mediated knockdown of hgsnat were confirmed to have a reduced level of HGSNAT transcripts and age‐dependent accumulation of heparan sulphate leading to engorgement of the endo/lysosomal compartment. This resulted in abnormalities at the pre‐synapse, defective climbing and reduced overall activity. Altered circadian rhythms (shift in peak morning activity) were seen in hgsnat neuronal knockdown lines. Further, when hgsnat was knocked down in specific glial subsets (wrapping, cortical, astrocytes or subperineural glia), impaired climbing or reduced activity was noted, implying that hgsnat function in these specific glial subtypes contributes significantly to this behaviour and targeting treatments to these cell groups may be necessary to ameliorate or prevent symptom onset. These novel models of MPS IIIC provide critical research tools for delineating the key cellular pathways causal in the onset of neurodegeneration in this presently untreatable disorder.
doi_str_mv 10.1002/jimd.12712
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2929059593</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2957146344</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3522-a54d24465154923cca2200e252ac6d03ab27665de0983c9ad81cf70eb796bf623</originalsourceid><addsrcrecordid>eNp9kcFu1DAQhq0K1C6FSx-gssSlIKW1x3ESH9EWaFCrIgHnyGtPdr1y4sXOCu2NR-AZeRK8bNsDBw6juXzza_7_J-SMs0vOGFyt3WAvOdQcjsiMy1oUUFXyGZkxXvKiUVKekBcprRljqpHymJyIBkTDmZqRdB1DCpuV85oO6PUYljpNGOkQLPpEQ0_vPn-hbdvO6cXNMo16-v3zl8XeGYej2b2hK7dc-TwTnVZIY_C4P1p6p6kbqXUJdUK6iZhwnPTkwviSPO-1T_jqYZ-Sbx_ef53fFLf3H9v5u9vCCAlQaFlaKMtKclkqEMZoAMYQJGhTWSb0Aurs02J2JYzStuGmrxkualUt-grEKbk46G5i-L7FNHWDSwZ9dolhmzpQoJhUUomMvv4HXYdtHPN3mZI1LytRlpl6e6BMDi1F7LtNdIOOu46zbl9Ft6-i-1tFhs8fJLeLAe0T-ph9BvgB-OE87v4j1X1q764Pon8APvGTpA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2957146344</pqid></control><display><type>article</type><title>Drosophila melanogaster models of MPS IIIC (Hgsnat‐deficiency) highlight the role of glia in disease presentation</title><source>Wiley-Blackwell Journals</source><creator>Hewson, Laura ; Choo, Amanda ; Webber, Dani L. ; Trim, Paul J. ; Snel, Marten F. ; Fedele, Anthony O. ; Hopwood, John J. ; Hemsley, Kim M. ; O'Keefe, Louise V.</creator><creatorcontrib>Hewson, Laura ; Choo, Amanda ; Webber, Dani L. ; Trim, Paul J. ; Snel, Marten F. ; Fedele, Anthony O. ; Hopwood, John J. ; Hemsley, Kim M. ; O'Keefe, Louise V.</creatorcontrib><description>Sanfilippo syndrome (Mucopolysaccharidosis type III or MPS III) is a recessively inherited neurodegenerative lysosomal storage disorder. Mutations in genes encoding enzymes in the heparan sulphate degradation pathway lead to the accumulation of partially degraded heparan sulphate, resulting ultimately in the development of neurological deficits. Mutations in the gene encoding the membrane protein heparan‐α‐glucosaminide N‐acetyltransferase (HGSNAT; EC2.3.1.78) cause MPS IIIC (OMIM#252930), typified by impaired cognition, sleep–wake cycle changes, hyperactivity and early death, often before adulthood. The precise disease mechanism that causes symptom emergence remains unknown, posing a significant challenge in the development of effective therapeutics. As HGSNAT is conserved in Drosophila melanogaster, we now describe the creation and characterisation of the first Drosophila models of MPS IIIC. Flies with either an endogenous insertion mutation or RNAi‐mediated knockdown of hgsnat were confirmed to have a reduced level of HGSNAT transcripts and age‐dependent accumulation of heparan sulphate leading to engorgement of the endo/lysosomal compartment. This resulted in abnormalities at the pre‐synapse, defective climbing and reduced overall activity. Altered circadian rhythms (shift in peak morning activity) were seen in hgsnat neuronal knockdown lines. Further, when hgsnat was knocked down in specific glial subsets (wrapping, cortical, astrocytes or subperineural glia), impaired climbing or reduced activity was noted, implying that hgsnat function in these specific glial subtypes contributes significantly to this behaviour and targeting treatments to these cell groups may be necessary to ameliorate or prevent symptom onset. These novel models of MPS IIIC provide critical research tools for delineating the key cellular pathways causal in the onset of neurodegeneration in this presently untreatable disorder.</description><identifier>ISSN: 0141-8955</identifier><identifier>EISSN: 1573-2665</identifier><identifier>DOI: 10.1002/jimd.12712</identifier><identifier>PMID: 38238109</identifier><language>eng</language><publisher>Hoboken, USA: John Wiley &amp; Sons, Inc</publisher><subject>Acetyltransferase ; animal model ; Astrocytes ; autosomal recessive ; Circadian rhythms ; Cognition ; drosophila ; Drosophila melanogaster ; Drug development ; Engorgement ; Heparan sulfate ; Hyperactivity ; inborn error of metabolism ; Insects ; lysosomal storage disorder ; Membrane proteins ; MPS IIIC ; Mucopolysaccharidosis ; Mutation ; Neurodegeneration ; Neurological diseases ; RNA-mediated interference ; Sleep and wakefulness ; Synapses ; synaptic abnormality</subject><ispartof>Journal of inherited metabolic disease, 2024-03, Vol.47 (2), p.340-354</ispartof><rights>2024 The Authors. published by John Wiley &amp; Sons Ltd on behalf of SSIEM.</rights><rights>2024 The Authors. Journal of Inherited Metabolic Disease published by John Wiley &amp; Sons Ltd on behalf of SSIEM.</rights><rights>2024. This article is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3522-a54d24465154923cca2200e252ac6d03ab27665de0983c9ad81cf70eb796bf623</cites><orcidid>0000-0003-1038-9884</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fjimd.12712$$EPDF$$P50$$Gwiley$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fjimd.12712$$EHTML$$P50$$Gwiley$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38238109$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hewson, Laura</creatorcontrib><creatorcontrib>Choo, Amanda</creatorcontrib><creatorcontrib>Webber, Dani L.</creatorcontrib><creatorcontrib>Trim, Paul J.</creatorcontrib><creatorcontrib>Snel, Marten F.</creatorcontrib><creatorcontrib>Fedele, Anthony O.</creatorcontrib><creatorcontrib>Hopwood, John J.</creatorcontrib><creatorcontrib>Hemsley, Kim M.</creatorcontrib><creatorcontrib>O'Keefe, Louise V.</creatorcontrib><title>Drosophila melanogaster models of MPS IIIC (Hgsnat‐deficiency) highlight the role of glia in disease presentation</title><title>Journal of inherited metabolic disease</title><addtitle>J Inherit Metab Dis</addtitle><description>Sanfilippo syndrome (Mucopolysaccharidosis type III or MPS III) is a recessively inherited neurodegenerative lysosomal storage disorder. Mutations in genes encoding enzymes in the heparan sulphate degradation pathway lead to the accumulation of partially degraded heparan sulphate, resulting ultimately in the development of neurological deficits. Mutations in the gene encoding the membrane protein heparan‐α‐glucosaminide N‐acetyltransferase (HGSNAT; EC2.3.1.78) cause MPS IIIC (OMIM#252930), typified by impaired cognition, sleep–wake cycle changes, hyperactivity and early death, often before adulthood. The precise disease mechanism that causes symptom emergence remains unknown, posing a significant challenge in the development of effective therapeutics. As HGSNAT is conserved in Drosophila melanogaster, we now describe the creation and characterisation of the first Drosophila models of MPS IIIC. Flies with either an endogenous insertion mutation or RNAi‐mediated knockdown of hgsnat were confirmed to have a reduced level of HGSNAT transcripts and age‐dependent accumulation of heparan sulphate leading to engorgement of the endo/lysosomal compartment. This resulted in abnormalities at the pre‐synapse, defective climbing and reduced overall activity. Altered circadian rhythms (shift in peak morning activity) were seen in hgsnat neuronal knockdown lines. Further, when hgsnat was knocked down in specific glial subsets (wrapping, cortical, astrocytes or subperineural glia), impaired climbing or reduced activity was noted, implying that hgsnat function in these specific glial subtypes contributes significantly to this behaviour and targeting treatments to these cell groups may be necessary to ameliorate or prevent symptom onset. These novel models of MPS IIIC provide critical research tools for delineating the key cellular pathways causal in the onset of neurodegeneration in this presently untreatable disorder.</description><subject>Acetyltransferase</subject><subject>animal model</subject><subject>Astrocytes</subject><subject>autosomal recessive</subject><subject>Circadian rhythms</subject><subject>Cognition</subject><subject>drosophila</subject><subject>Drosophila melanogaster</subject><subject>Drug development</subject><subject>Engorgement</subject><subject>Heparan sulfate</subject><subject>Hyperactivity</subject><subject>inborn error of metabolism</subject><subject>Insects</subject><subject>lysosomal storage disorder</subject><subject>Membrane proteins</subject><subject>MPS IIIC</subject><subject>Mucopolysaccharidosis</subject><subject>Mutation</subject><subject>Neurodegeneration</subject><subject>Neurological diseases</subject><subject>RNA-mediated interference</subject><subject>Sleep and wakefulness</subject><subject>Synapses</subject><subject>synaptic abnormality</subject><issn>0141-8955</issn><issn>1573-2665</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><recordid>eNp9kcFu1DAQhq0K1C6FSx-gssSlIKW1x3ESH9EWaFCrIgHnyGtPdr1y4sXOCu2NR-AZeRK8bNsDBw6juXzza_7_J-SMs0vOGFyt3WAvOdQcjsiMy1oUUFXyGZkxXvKiUVKekBcprRljqpHymJyIBkTDmZqRdB1DCpuV85oO6PUYljpNGOkQLPpEQ0_vPn-hbdvO6cXNMo16-v3zl8XeGYej2b2hK7dc-TwTnVZIY_C4P1p6p6kbqXUJdUK6iZhwnPTkwviSPO-1T_jqYZ-Sbx_ef53fFLf3H9v5u9vCCAlQaFlaKMtKclkqEMZoAMYQJGhTWSb0Aurs02J2JYzStuGmrxkualUt-grEKbk46G5i-L7FNHWDSwZ9dolhmzpQoJhUUomMvv4HXYdtHPN3mZI1LytRlpl6e6BMDi1F7LtNdIOOu46zbl9Ft6-i-1tFhs8fJLeLAe0T-ph9BvgB-OE87v4j1X1q764Pon8APvGTpA</recordid><startdate>202403</startdate><enddate>202403</enddate><creator>Hewson, Laura</creator><creator>Choo, Amanda</creator><creator>Webber, Dani L.</creator><creator>Trim, Paul J.</creator><creator>Snel, Marten F.</creator><creator>Fedele, Anthony O.</creator><creator>Hopwood, John J.</creator><creator>Hemsley, Kim M.</creator><creator>O'Keefe, Louise V.</creator><general>John Wiley &amp; Sons, Inc</general><general>Blackwell Publishing Ltd</general><scope>24P</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7TK</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-1038-9884</orcidid></search><sort><creationdate>202403</creationdate><title>Drosophila melanogaster models of MPS IIIC (Hgsnat‐deficiency) highlight the role of glia in disease presentation</title><author>Hewson, Laura ; Choo, Amanda ; Webber, Dani L. ; Trim, Paul J. ; Snel, Marten F. ; Fedele, Anthony O. ; Hopwood, John J. ; Hemsley, Kim M. ; O'Keefe, Louise V.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3522-a54d24465154923cca2200e252ac6d03ab27665de0983c9ad81cf70eb796bf623</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Acetyltransferase</topic><topic>animal model</topic><topic>Astrocytes</topic><topic>autosomal recessive</topic><topic>Circadian rhythms</topic><topic>Cognition</topic><topic>drosophila</topic><topic>Drosophila melanogaster</topic><topic>Drug development</topic><topic>Engorgement</topic><topic>Heparan sulfate</topic><topic>Hyperactivity</topic><topic>inborn error of metabolism</topic><topic>Insects</topic><topic>lysosomal storage disorder</topic><topic>Membrane proteins</topic><topic>MPS IIIC</topic><topic>Mucopolysaccharidosis</topic><topic>Mutation</topic><topic>Neurodegeneration</topic><topic>Neurological diseases</topic><topic>RNA-mediated interference</topic><topic>Sleep and wakefulness</topic><topic>Synapses</topic><topic>synaptic abnormality</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hewson, Laura</creatorcontrib><creatorcontrib>Choo, Amanda</creatorcontrib><creatorcontrib>Webber, Dani L.</creatorcontrib><creatorcontrib>Trim, Paul J.</creatorcontrib><creatorcontrib>Snel, Marten F.</creatorcontrib><creatorcontrib>Fedele, Anthony O.</creatorcontrib><creatorcontrib>Hopwood, John J.</creatorcontrib><creatorcontrib>Hemsley, Kim M.</creatorcontrib><creatorcontrib>O'Keefe, Louise V.</creatorcontrib><collection>Wiley Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of inherited metabolic disease</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hewson, Laura</au><au>Choo, Amanda</au><au>Webber, Dani L.</au><au>Trim, Paul J.</au><au>Snel, Marten F.</au><au>Fedele, Anthony O.</au><au>Hopwood, John J.</au><au>Hemsley, Kim M.</au><au>O'Keefe, Louise V.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Drosophila melanogaster models of MPS IIIC (Hgsnat‐deficiency) highlight the role of glia in disease presentation</atitle><jtitle>Journal of inherited metabolic disease</jtitle><addtitle>J Inherit Metab Dis</addtitle><date>2024-03</date><risdate>2024</risdate><volume>47</volume><issue>2</issue><spage>340</spage><epage>354</epage><pages>340-354</pages><issn>0141-8955</issn><eissn>1573-2665</eissn><abstract>Sanfilippo syndrome (Mucopolysaccharidosis type III or MPS III) is a recessively inherited neurodegenerative lysosomal storage disorder. Mutations in genes encoding enzymes in the heparan sulphate degradation pathway lead to the accumulation of partially degraded heparan sulphate, resulting ultimately in the development of neurological deficits. Mutations in the gene encoding the membrane protein heparan‐α‐glucosaminide N‐acetyltransferase (HGSNAT; EC2.3.1.78) cause MPS IIIC (OMIM#252930), typified by impaired cognition, sleep–wake cycle changes, hyperactivity and early death, often before adulthood. The precise disease mechanism that causes symptom emergence remains unknown, posing a significant challenge in the development of effective therapeutics. As HGSNAT is conserved in Drosophila melanogaster, we now describe the creation and characterisation of the first Drosophila models of MPS IIIC. Flies with either an endogenous insertion mutation or RNAi‐mediated knockdown of hgsnat were confirmed to have a reduced level of HGSNAT transcripts and age‐dependent accumulation of heparan sulphate leading to engorgement of the endo/lysosomal compartment. This resulted in abnormalities at the pre‐synapse, defective climbing and reduced overall activity. Altered circadian rhythms (shift in peak morning activity) were seen in hgsnat neuronal knockdown lines. Further, when hgsnat was knocked down in specific glial subsets (wrapping, cortical, astrocytes or subperineural glia), impaired climbing or reduced activity was noted, implying that hgsnat function in these specific glial subtypes contributes significantly to this behaviour and targeting treatments to these cell groups may be necessary to ameliorate or prevent symptom onset. These novel models of MPS IIIC provide critical research tools for delineating the key cellular pathways causal in the onset of neurodegeneration in this presently untreatable disorder.</abstract><cop>Hoboken, USA</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>38238109</pmid><doi>10.1002/jimd.12712</doi><tpages>15</tpages><orcidid>https://orcid.org/0000-0003-1038-9884</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0141-8955
ispartof Journal of inherited metabolic disease, 2024-03, Vol.47 (2), p.340-354
issn 0141-8955
1573-2665
language eng
recordid cdi_proquest_miscellaneous_2929059593
source Wiley-Blackwell Journals
subjects Acetyltransferase
animal model
Astrocytes
autosomal recessive
Circadian rhythms
Cognition
drosophila
Drosophila melanogaster
Drug development
Engorgement
Heparan sulfate
Hyperactivity
inborn error of metabolism
Insects
lysosomal storage disorder
Membrane proteins
MPS IIIC
Mucopolysaccharidosis
Mutation
Neurodegeneration
Neurological diseases
RNA-mediated interference
Sleep and wakefulness
Synapses
synaptic abnormality
title Drosophila melanogaster models of MPS IIIC (Hgsnat‐deficiency) highlight the role of glia in disease presentation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T18%3A39%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Drosophila%20melanogaster%20models%20of%20MPS%20IIIC%20(Hgsnat%E2%80%90deficiency)%20highlight%20the%20role%20of%20glia%20in%20disease%20presentation&rft.jtitle=Journal%20of%20inherited%20metabolic%20disease&rft.au=Hewson,%20Laura&rft.date=2024-03&rft.volume=47&rft.issue=2&rft.spage=340&rft.epage=354&rft.pages=340-354&rft.issn=0141-8955&rft.eissn=1573-2665&rft_id=info:doi/10.1002/jimd.12712&rft_dat=%3Cproquest_cross%3E2957146344%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2957146344&rft_id=info:pmid/38238109&rfr_iscdi=true